Sort
15,273 grants matching “antimicrobial resistance”
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
$639,543Qi Zhou · Purdue University · R01 · FY2022 · AI
Metallothionein-Zinc Axis and Macrophage Memory to Fungi
$639,496George S. Deepe · University Of Cincinnati · R01 · FY2025 · AI
Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses
$639,235Ann R Falsey · University Of Rochester · R01 · FY2021 · AI
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$639,196John J Mekalanos · Harvard Medical School · R01 · FY2011 · AI
Rapid and Expandable Nucleic Acid Platform to Detect Bloodstream Infections
$638,889David S Perlin · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2007 · AI
Pay-it-forward gonorrhea testing among men who have sex with men: The PIONEER pragmatic randomized controlled trial
$638,835Joseph David Tucker · Univ Of North Carolina Chapel Hill · R01 · FY2021 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$638,651Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2022 · AI
The role of the microbiome in childhood disease
$638,646Suchitra Hourigan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Collaborative Research: GCR: Infection-Resisting Resorbable Scaffolds for Engineering Human Tissue
$638,422Shikha Nangia · Syracuse University · · FY2022 · O/D
Role of Host Protein Kinase C in Cryptosporidiosis
$638,364Chelsea S. Marie · University Of Virginia · R01 · FY2021 · AI
Pathogen and immune-topographic mechanisms that underpin Candida auris skin colonization
$638,315Suzanne M Noble · University Of California, San Francisco · R01 · FY2025 · AR
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
$638,200Theresa A Freeman · Thomas Jefferson University · R01 · FY2025 · AR
An Expanded Multivalent Vaccine to Prevent MDR Shigella and ETEC Disease
$638,173Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2022 · AI
On-site, high-fidelity target sequencing and absolute quantitation for HIV-1 surveillance
$638,025Sanggu Kim · Ohio State University · R01 · FY2019 · HG
Microbial Ecology-Guided Discovery of Antibacterial Drugs
$637,929Eric W Schmidt · University Of Utah · R01 · FY2023 · AI
Lung-Protective Mechanisms of Metformin in TB
$637,617Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HL
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
$637,431Lars Eckmann · University Of California, San Diego · R01 · FY2015 · AI
New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
$637,370Saumendra N Sarkar · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
RIVUR Study
$637,369Tej K Mattoo · Wayne State University · U01 · FY2010 · DK
Microbial Ecology-Guided Discovery of Antibacterial Drugs
$637,153Eric W Schmidt · University Of Utah · R01 · FY2024 · AI
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income Countries
$637,037Margaret N Kosek · University Of Virginia · R01 · FY2023 · AI
Project 1: Co-stimulation and Regulation of Anti-viral Immunity
$637,015Arlene H Sharpe · Harvard Medical School · P01 · FY2023 · AI
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$636,937John J Mekalanos · Harvard Medical School · R01 · FY2012 · AI
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2024 · AI